Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries - UFR SVE Sciences de la vie et de l'environnement Accéder directement au contenu
Article Dans Une Revue Journal of Antimicrobial Chemotherapy Année : 2022

Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries

Résumé

OBJECTIVES: To determine clinical practice variation and identify knowledge gaps in antibiotic treatment of Staphylococcus aureus bacteraemia (SAB). METHODS: A web-based survey with questions addressing antibiotic treatment of SAB was distributed through the ESGAP network among infectious disease specialists, clinical microbiologists and internists in Croatia, France, Greece, the Netherlands and the UK between July 2021 and November 2021. RESULTS: A total number of 1687 respondents opened the survey link, of whom 677 (40%) answered at least one question. For MSSA and MRSA bacteraemia, 98% and 94% preferred initial monotherapy, respectively. In patients with SAB and non-removable infected prosthetic material, between 80% and 90% would use rifampicin as part of the treatment. For bone and joint infections, 65%-77% of respondents would consider oral step-down therapy, but for endovascular infections only 12%-32% would. Respondents recommended widely varying treatment durations for SAB with different foci of infection. Overall, 48% stated they used 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG-PET/CT) to guide antibiotic treatment duration. Persistent bacteraemia was the only risk factor for complicated SAB that would prompt a majority to extend treatment from 2 to 4-6 weeks. CONCLUSIONS: This survey in five European countries shows considerable clinical practice variation between and within countries in the antibiotic management of SAB, in particular regarding oral step-down therapy, choice of oral antibiotic agents, treatment duration and use of 18F-FDG-PET/CT. Physicians use varying criteria for treatment decisions, as evidence from clinical trials is often lacking. These areas of practice variation could be used to prioritize future studies for further improvement of SAB care.
Fichier principal
Vignette du fichier
dkac237.pdf (320.48 Ko) Télécharger le fichier
dkac237_supplementary_data.pdf (434.15 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03777270 , version 1 (19-02-2024)

Licence

Paternité

Identifiants

Citer

D T P Buis, J M Prins, L Betica-Radic, M G J de Boer, M Ekkelenkamp, et al.. Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries. Journal of Antimicrobial Chemotherapy, 2022, 77 (10), pp.2827-2834. ⟨10.1093/jac/dkac237⟩. ⟨hal-03777270⟩
28 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More